<DOC>
	<DOCNO>NCT02859389</DOCNO>
	<brief_summary>Survivors acute lymphoblastic leukemia ( ALL ) risk neurocognitive deficit , reduce educational psychosocial outcome , low quality life . Neurocognitive assessment frequently implement therapy continue survivorship monitor function facilitate intervention . Children Down Syndrome ( DS ) 10 20-fold increase risk leukemia . Survival rate leukemia patient DS comparable low patient without DS , however , patient great risk treatment-related toxicity . Children preexist neurodevelopmental condition , include DS , systematically exclude neurocognitive assessment clinical trial , contribute gap investigator understand outcome patient preexist neurocognitive vulnerability . The investigator propose novel preliminary investigation functional outcome child DS childhood leukemia . This study implications future treatment leukemia patient DS , may generalize leukemia patient predisposition preexist neurodevelopmental condition ( e.g. , genetic disorder , acquire brain injury , autism , epilepsy ) . Primary Objective : - To describe neurocognitive psychosocial outcome survivor childhood leukemia Down Syndrome use novel assessment approach .</brief_summary>
	<brief_title>Neurocognitive Psychosocial Outcomes Survivors Childhood Leukemia With Down Syndrome</brief_title>
	<detailed_description>The investigator recruit survivor childhood leukemia DS participate one-time assessment neurocognitive psychosocial functioning . Potentially eligible family identify via medical record review St. Jude Children 's Research Hospital ( SJCRH ) contact discus study objective , assess interest , confirm eligibility . Eligible family schedule one study visit , estimate last 2.5 hour . Participants provide inform consent prior start study procedure . Survivors â‰¥ 5 year old complete performance-based neurocognitive measure . Caregivers ( i.e. , parent legal guardian ) participant , regardless age , complete rating executive function , behavior , adaptive skill . Participants ask identify provide write permission contact secondary informant ( e.g. , teacher work supervisor ) . Identified informant contact study team member ask complete behavior rating scale .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Patient SJCRH patient diagnosis leukemia . Diagnosis Trisomy 21 DS document medical record Completed cancerdirected therapy SJCRH , since 1980 , least 6 month prior study visit English primary language Documented history central nervous system ( CNS ) injury disease occur complete cancerdirected therapy History current substance use abuse</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Down Syndrome</keyword>
	<keyword>Neurocognitive</keyword>
	<keyword>Survivorship</keyword>
	<keyword>Attention</keyword>
	<keyword>Executive function</keyword>
	<keyword>Late effect</keyword>
</DOC>